Binoculars; cell phone cases; computer mouse; computer mouse pads; headphones; sunglasses

Jewelry

Children's books; drawing rulers; erasers; maps; paper flags; paper napkins; paper place mats; pencil cases; postcards; rubber stamps; scrapbooks; stamp pads

Backpacks; book bags; umbrellas

Storage boxes for memorabilia; wicker baskets;

Bowls; cups; dishes; hair brushes and hair combs; mugs; picnic baskets; place mats of plastic not being a textile substitute; plates; tooth brushes

Bed and bath linens; cloth flags; textile place mats

Athletic footwear; casual clothing; casual footwear; clothing for babies; clothing for children; footwear for children; housecoats; night shirts; pajamas; pants; shirts, t-shirts, hats, sweatshirts; shorts; smocks; thong sandals

Beach toys; board games; collectible toy figures; plush toys; puppets; rocking horses; teddy bears; toy figures; toys and games, namely puzzles and jigsaw puzzles

Drink mixes, namely, concentrates, syrups or powders used in the preparation of soft drinks and/or non-alcoholic cocktail beverages;

Training of site staff in administering medicine and testing, completing patient documentation, and using technology, in the field of pharmaceutical studies; provision of a website featuring temporary online non-downloadable publications in the nature of reports, articles and presentations in the fields of clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); provision of temporary online non-downloadable educational webinars in the field of clinical trials.

Providing temporary use of non-downloadable software and applications for use in database management and support for use in data collection in connection with clinical trials; medical and scientific research, data collection and data analysis in the nature of clinical research and clinical trials in the fields of health care, medical care and pharmaceutical use; provision of an internet based database for data entry and management, electronic approval and audit trail capture in the field of pharmaceutical research and development purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture to conduct clinical trials for pharmaceutical research and development purposes featuring scientific research information on complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture for pharmaceutical research and development purposes designed to monitor and provide real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture to conduct clinical trials in the field of clinical trials for pharmaceutical research and development purposes featuring scientific research information for monitoring and providing real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); provision of platforms on the internet relating to the field of clinical trials; provision of temporary online non-downloadable computer programs for data entry and management, electronic approval and audit trail capture in data networks relating to the fields of clinical trials; design and development of computer software relating to the field of clinical trials; maintenance and updating of computer software relating to the field of clinical trials; provision of a web site for internet storage space, namely, to store data relating to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); data administration on servers relating to clinical trials data (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); application service provider (ASP), namely, hosting computer software applications for others, namely, for clinical trials; providing a website featuring technology that enables patients to upload and publicly share data from blood sugar meters for diabetes management purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); computer services, namely, provision of search platforms in the nature of temporary online non-downloadable software to manage diabetes management data; computer services, namely, provision of platforms on the Internet in the nature of temporary non-downloadable software to manage data on diabetes management; software as a service (SAAS) services featuring software for hosting, managing, and transmitting patient data and communicating with patients via video consults, messaging and surveys; software as a service (SAAS) services featuring software for capturing medical data from patients for the purpose of remote patient monitoring and care coordination; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices including handhelds, PDAs, web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinician and observer reported outcomes on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for interfacing and integrating with third party clinical systems to enable transferring, collecting, viewing, and sharing of clinical study data; providing a website featuring blogs, reports, articles and presentations in the fields of clinical trials; software as a service (SAAS) services featuring software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, all of which information is added to existing study questionnaires as a way to record concomitant medications (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinical outcomes assessments on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for conveying to patients information related to a clinical trial using interactive multimedia and for enabling patients to dynamically engage, review, question and agree to participate in a clinical trial, featuring tiered information delivery, interactive assessments, interactive communication of questions to the clinical trial staff, and to generate information and reports, and featuring a development platform allowing users to collaboratively design and develop content across multiple stakeholders; software as a service (SAAS) services featuring software for processing and presenting patient data; software as a service (SAAS) services featuring software for enabling patients to enroll in a clinical study; software as a service (SAAS) services featuring software for enabling users to view, manage and report on patient reported data in pharmaceutical industry clinical trials; software as a service (SAAS) services featuring software for the development, design, localization and simulation of electronic clinical outcome assessments for pharmaceutical industry clinical trials; consulting services in the design and implementation of computer based information systems related to clinical trial and supply management; consulting services in the design and implementation of computer based information systems in connection with clinical research and clinical trials; computer software development and computer software consulting services for use in the fields of pharmaceutical research, biotechnology, clinical trials and supply management; scientific study planning in the field of clinical trials; rental services relating to data processing equipment and computers for use in clinical studies; scientific study data analysis in the field of pharmaceuticals; medical and scientific research, namely, collecting, monitoring and evaluating patient and clinical data; temporary online non-downloadable communication software, pharmaceutical industry clinical trial software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information, including patient reported outcomes and clinical outcomes assessments, on computing devices (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).